Skip to main content
. 2021 Feb 8;40(3):661–674. doi: 10.1007/s10555-020-09953-z

Fig. 4.

Fig. 4

Although therapies may successfully kill most of the neoplastic cells, small populations of pre-existing neoplastic cells with genetic alterations that allow them to survive the selective pressure of the therapy will emerge to form drug-resistant clones